Skip to main content

Licensing in

We are interested in licensing in or acquiring new products, technologies and projects. Our priority areas are currently:

 

  • OTC products for the U.S. market
  • Products for the Nordic region and the UK, primarily dermatology and women’s healthcare
  • Dermatotology projects and technologies with limited development risk (no NCEs)
  • Drug Delivery projects and technologies with limited development risk
     

Welcome to contact us!
 

Email: bd@mobergpharma.se